Trinity Health and pharmaceutical company team up to fight opioid use — 4 takeaways

Written by Adam Schrag | March 30, 2017 | Print  |

Livonia, Mich.-based Trinity Health and Parsippany, N.J.-based Pacira Pharmaceuticals have announced a collaboration to find alternatives to opioids for pain management, according to NJ Biz.

Here are four things to know:


1. The collaborators hope to improve the economics of acute care between a healthcare system and the pharmaceutical industry. The data will help develop new protocols and products.


2. Patients most likely to benefit from the efforts will be identified and Trinity Health and Pacira Pharmaceuticals will seek approaches to reduce or replace opioid use in post-surgical care.


3. Trinity Health Vice President of Clinical Quality and Patient Safety Paul Conlon said, "We are pleased to be working with Pacira to develop a more people-centered approach for pain management across the many diverse communities we serve."


4. Pacira Chairman and CEO Dave Stack said, "By working collectively to develop, disseminate and educate on these enhanced recovery protocols, and thus reducing exposure to debilitating and costly opioid-related adverse events or longer-term societal burden, we are truly advancing patient care."


More articles on practice management:
Dr. Zarina Ali strives to be mentor for future female neurosurgeons— 5 highlights

Iowa is the best state for physicians — Which is the worst?

Athenahealth Marketplace partners cut costs and save time for providers — 4 highlights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months